Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 9
1992 24
1993 29
1994 40
1995 94
1996 102
1997 128
1998 173
1999 226
2000 269
2001 363
2002 357
2003 386
2004 440
2005 510
2006 511
2007 543
2008 531
2009 625
2010 628
2011 710
2012 647
2013 688
2014 584
2015 568
2016 466
2017 453
2018 380
2019 216
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

9,585 results
Results by year
Filters applied: . Clear all
Page 1
NFKB1: a suppressor of inflammation, ageing and cancer.
Cartwright T, Perkins ND, L Wilson C. Cartwright T, et al. FEBS J. 2016 May;283(10):1812-22. doi: 10.1111/febs.13627. Epub 2016 Jan 13. FEBS J. 2016. PMID: 26663363 Free article. Review.
Targeting IKK and NF-κB for Therapy.
Durand JK, Baldwin AS. Durand JK, et al. Adv Protein Chem Struct Biol. 2017;107:77-115. doi: 10.1016/bs.apcsb.2016.11.006. Epub 2017 Jan 11. Adv Protein Chem Struct Biol. 2017. PMID: 28215229 Review.
Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia.
Lynch DR, Farmer J, Hauser L, Blair IA, Wang QQ, Mesaros C, Snyder N, Boesch S, Chin M, Delatycki MB, Giunti P, Goldsberry A, Hoyle C, McBride MG, Nachbauer W, O'Grady M, Perlman S, Subramony SH, Wilmot GR, Zesiewicz T, Meyer C. Lynch DR, et al. Ann Clin Transl Neurol. 2018 Nov 10;6(1):15-26. doi: 10.1002/acn3.660. eCollection 2019 Jan. Ann Clin Transl Neurol. 2018. PMID: 30656180 Free PMC article. Clinical Trial.
9,585 results
Jump to page
Feedback